1. Home
  2. BRCC vs PYXS Comparison

BRCC vs PYXS Comparison

Compare BRCC & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRC Inc.

BRCC

BRC Inc.

HOLD

Current Price

$0.85

Market Cap

152.1M

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$2.75

Market Cap

141.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCC
PYXS
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.1M
141.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
BRCC
PYXS
Price
$0.85
$2.75
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$2.25
$7.00
AVG Volume (30 Days)
892.0K
967.1K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.03
EPS
N/A
N/A
Revenue
$398,263,000.00
$13,858,000.00
Revenue This Year
$9.68
N/A
Revenue Next Year
$9.59
$7,043.98
P/E Ratio
N/A
N/A
Revenue Growth
1.73
N/A
52 Week Low
$0.60
$1.02
52 Week High
$1.86
$5.55

Technical Indicators

Market Signals
Indicator
BRCC
PYXS
Relative Strength Index (RSI) 29.70 44.51
Support Level $0.66 $1.37
Resistance Level $1.34 $2.92
Average True Range (ATR) 0.11 0.42
MACD -0.02 0.02
Stochastic Oscillator 0.51 28.10

Price Performance

Historical Comparison
BRCC
PYXS

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma. Its product candidate, micvotabart pelidotin (MICVO, formerly PYX-201), is an investigational antibody-drug conjugate that targets extradomain-B fibronectin (EDB+FN), a component of the tumor extracellular matrix that is expressed in tumors and minimally present in normal tissues. MICVO consists of a fully human monoclonal antibody linked to a microtubule inhibitor payload, designed to bind within the tumor microenvironment and release its payload to kill cancer cells directly, affect nearby cells through a bystander effect, and induce immunogenic cell death, supporting enhanced anti-tumor activity.

Share on Social Networks: